Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5446 AL 5460

Amyloid imaging: liberal or conservative? Let the data decide

Jagust WJ.

Arch Neurol. 2011 Nov;68(11):1377-8. doi: 10.1001/archneurol.2011.152. Epub 2011 Jul 11.

Structural imaging in early pre-states of dementia

Smith CD.

Biochim Biophys Acta. 2012 Mar;1822(3):317-24. doi: 10.1016/j.bbadis.2011.07.002. Epub 2011 Jul 14.

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia.

Stroke. 2011 Sep;42(9):2672-713. doi: 10.1161/STR.0b013e3182299496. Epub 2011 Jul 21.

[Diabetes mellitus and cognitive decline]

Iglseder B.

Wien Med Wochenschr. 2011 Nov;161(21-22):524-30. doi: 10.1007/s10354-011-0003-x. Epub 2011 Jul 29.

Detecting cognitive impairment by eye movement analysis using automatic classification algorithms

Lagun D, Manzanares C, Zola SM, Buffalo EA, Agichtein E.

J Neurosci Methods. 2011 Sep 30;201(1):196-203. doi: 10.1016/j.jneumeth.2011.06.027. Epub 2011 Jul 27.

White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions

Gold BT, Johnson NF, Powell DK, Smith CD.

Biochim Biophys Acta. 2012 Mar;1822(3):416-22. doi: 10.1016/j.bbadis.2011.07.009. Epub 2011 Jul 23.

Consequences of antipsychotic medications for the dementia patient

Devanand DP, Schultz SK.

Am J Psychiatry. 2011 Aug;168(8):767-9. doi: 10.1176/appi.ajp.2011.11040629.

Neuropsychiatric symptoms in Alzheimer's disease

Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS.

Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410.

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B.

Arch Neurol. 2012 Jan;69(1):29-38. doi: 10.1001/archneurol.2011.233. Epub 2011 Sep 12.

Presenile dementia diagnosed as posterior cortical atrophy

Tsunoda A, Iritani S, Ozaki N.

Psychogeriatrics. 2011 Sep;11(3):171-6. doi: 10.1111/j.1479-8301.2011.00366.x. Epub 2011 Jun 15.

Screening for dementia: an opportunity for debate

Ballard C, Corbett A.

Expert Rev Neurother. 2011 Oct;11(10):1347-9. doi: 10.1586/ern.11.121.

Effects of hypoperfusion in Alzheimer's disease

Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V.

J Alzheimers Dis. 2011;26 Suppl 3(Suppl 3):123-33. doi: 10.3233/JAD-2011-0010.

Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease

Fellgiebel A, Yakushev I.

J Alzheimers Dis. 2011;26 Suppl 3:257-62. doi: 10.3233/JAD-2011-0001.

Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease

Förster S, Buschert VC, Teipel SJ, Friese U, Buchholz HG, Drzezga A, Hampel H, Bartenstein P, Buerger K.

J Alzheimers Dis. 2011;26 Suppl 3:337-48. doi: 10.3233/JAD-2011-0025.

Power calculations for clinical trials in Alzheimer's disease

Ard MC, Edland SD.

J Alzheimers Dis. 2011;26 Suppl 3(Suppl 3):369-77. doi: 10.3233/JAD-2011-0062.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias